BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

831 related articles for article (PubMed ID: 31581940)

  • 21. Validation of expression patterns for nine miRNAs in 204 lymph-node negative breast cancers.
    Jonsdottir K; Janssen SR; Da Rosa FC; Gudlaugsson E; Skaland I; Baak JP; Janssen EA
    PLoS One; 2012; 7(11):e48692. PubMed ID: 23144930
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Aberrant miRNAs expressed in HER-2 negative breast cancers patient.
    Braicu C; Raduly L; Morar-Bolba G; Cojocneanu R; Jurj A; Pop LA; Pileczki V; Ciocan C; Moldovan A; Irimie A; Eniu A; Achimas-Cadariu P; Paradiso A; Berindan-Neagoe I
    J Exp Clin Cancer Res; 2018 Oct; 37(1):257. PubMed ID: 30342533
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Analysis of differential expression profile of miRNA in peripheral blood of patients with lung cancer.
    He Q; Fang Y; Lu F; Pan J; Wang L; Gong W; Fei F; Cui J; Zhong J; Hu R; Liang M; Fang L; Wang H; Yu M; Zhang ZF
    J Clin Lab Anal; 2019 Nov; 33(9):e23003. PubMed ID: 31541491
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Oral squamous cell carcinoma: microRNA expression profiling and integrative analyses for elucidation of tumourigenesis mechanism.
    Manikandan M; Deva Magendhra Rao AK; Arunkumar G; Manickavasagam M; Rajkumar KS; Rajaraman R; Munirajan AK
    Mol Cancer; 2016 Apr; 15():28. PubMed ID: 27056547
    [TBL] [Abstract][Full Text] [Related]  

  • 25. MicroRNA profiles of healthy basal and luminal mammary epithelial cells are distinct and reflected in different breast cancer subtypes.
    Bockmeyer CL; Christgen M; Müller M; Fischer S; Ahrens P; Länger F; Kreipe H; Lehmann U
    Breast Cancer Res Treat; 2011 Dec; 130(3):735-45. PubMed ID: 21409395
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Four miRNAs associated with aggressiveness of lymph node-negative, estrogen receptor-positive human breast cancer.
    Foekens JA; Sieuwerts AM; Smid M; Look MP; de Weerd V; Boersma AW; Klijn JG; Wiemer EA; Martens JW
    Proc Natl Acad Sci U S A; 2008 Sep; 105(35):13021-6. PubMed ID: 18755890
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Expression of micrornas in molecular genetic breast cancer subtypes.
    Kolesnikov NN; Veryaskina YA; Titov SE; Rodionov VV; Gening TP; Abakumova TV; Kometova VV; Torosyan MK; Zhimulev IF
    Cancer Treat Res Commun; 2019; 20():100026. PubMed ID: 31255253
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical evaluation of microRNA expression profiling in non small cell lung cancer.
    Markou A; Sourvinou I; Vorkas PA; Yousef GM; Lianidou E
    Lung Cancer; 2013 Sep; 81(3):388-396. PubMed ID: 23756108
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Age-related microRNAs in older breast cancer patients: biomarker potential and evolution during adjuvant chemotherapy.
    Dalmasso B; Hatse S; Brouwers B; Laenen A; Berben L; Kenis C; Smeets A; Neven P; Schöffski P; Wildiers H
    BMC Cancer; 2018 Oct; 18(1):1014. PubMed ID: 30348127
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Expression of Estrogen Receptor- and Progesterone Receptor-Regulating MicroRNAs in Breast Cancer.
    Kalinina T; Kononchuk V; Alekseenok E; Obukhova D; Sidorov S; Strunkin D; Gulyaeva L
    Genes (Basel); 2021 Apr; 12(4):. PubMed ID: 33923732
    [TBL] [Abstract][Full Text] [Related]  

  • 31. MiR-190b, the highest up-regulated miRNA in ERα-positive compared to ERα-negative breast tumors, a new biomarker in breast cancers?
    Cizeron-Clairac G; Lallemand F; Vacher S; Lidereau R; Bieche I; Callens C
    BMC Cancer; 2015 Jul; 15():499. PubMed ID: 26141719
    [TBL] [Abstract][Full Text] [Related]  

  • 32. MicroRNA-143-5p Suppresses ER-Positive Breast Cancer Development by Targeting Oncogenic HMGA2.
    Mansoori B; Kiani S; Mezajin AA; Zandi P; Banaie H; Rostamzadeh D; Cho WC; Duijf PHG; Mansoori B; Baradaran B
    Clin Breast Cancer; 2023 Oct; 23(7):e480-e490.e3. PubMed ID: 37596147
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A two-miRNA signature of upregulated miR-185-5p and miR-362-5p as a blood biomarker for breast cancer.
    Zhang K; Wang YY; Xu Y; Zhang L; Zhu J; Si PC; Wang YW; Ma R
    Pathol Res Pract; 2021 Jun; 222():153458. PubMed ID: 33962174
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Biologic profiling of lymph node negative breast cancers by means of microRNA expression.
    Janssen EA; Slewa A; Gudlaugsson E; Jonsdottir K; Skaland I; Søiland H; Baak JP
    Mod Pathol; 2010 Dec; 23(12):1567-76. PubMed ID: 20818337
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Identification of microRNA biomarkers in the blood of breast cancer patients based on microRNA profiling.
    Zhang K; Wang YW; Wang YY; Song Y; Zhu J; Si PC; Ma R
    Gene; 2017 Jul; 619():10-20. PubMed ID: 28359916
    [TBL] [Abstract][Full Text] [Related]  

  • 36. MicroRNA profiling implies new markers of chemoresistance of triple-negative breast cancer.
    Ouyang M; Li Y; Ye S; Ma J; Lu L; Lv W; Chang G; Li X; Li Q; Wang S; Wang W
    PLoS One; 2014; 9(5):e96228. PubMed ID: 24788655
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Peritoneal fluid modifies the microRNA expression profile in endometrial and endometriotic cells from women with endometriosis.
    Braza-Boïls A; Salloum-Asfar S; Marí-Alexandre J; Arroyo AB; González-Conejero R; Barceló-Molina M; García-Oms J; Vicente V; Estellés A; Gilabert-Estellés J; Martínez C
    Hum Reprod; 2015 Oct; 30(10):2292-302. PubMed ID: 26307093
    [TBL] [Abstract][Full Text] [Related]  

  • 38. miRNA as potential biomarkers of breast cancer in the Lebanese population and in young women: a pilot study.
    Nassar FJ; El Sabban M; Zgheib NK; Tfayli A; Boulos F; Jabbour M; El Saghir NS; Talhouk R; Bazarbachi A; Calin GA; Nasr R
    PLoS One; 2014; 9(9):e107566. PubMed ID: 25232827
    [TBL] [Abstract][Full Text] [Related]  

  • 39. MicroRNA and LncRNA Expression Profiles in Human Estrogen Receptor Positive Breast Cancer.
    Shao X; Huang P; Shi L; Lei L; Cao W; Chen Z; Wang X; Zheng Y
    Clin Lab; 2019 Jan; 65(1):. PubMed ID: 30775882
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Stepwise analysis of MIR9 loci identifies miR-9-5p to be involved in Oestrogen regulated pathways in breast cancer patients.
    Barbano R; Pasculli B; Rendina M; Fontana A; Fusilli C; Copetti M; Castellana S; Valori VM; Morritti M; Graziano P; Luigi C; Coco M; Picardo F; Mazza T; Evron E; Murgo R; Maiello E; Esteller M; Fazio VM; Parrella P
    Sci Rep; 2017 Mar; 7():45283. PubMed ID: 28345661
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 42.